SCHEMBL17034874

SCHEMBL17034874

c1cncc(-c2cc(-c3ccc(-c4nc5ccccc5c5c4ccc4ccccc45)cc3)cc(-c3cccnc3)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.48
CYP11B1 P15538 2/20 0.48
CYP17A1 P05093 1/20 0.48
CYP11B2 P19099 1/20 0.48
DHODH Q02127 2/20 0.47
CYP2A6 P11509 1/20 0.45
CYP1A2 P05177 4/20 0.42
KDM4E B2RXH2 4/20 0.42
KMT2A Q03164 3/20 0.42
CYP1A1 P04798 1/20 0.42
PRKDC P78527 1/20 0.42
CYP1B1 Q16678 1/20 0.42
HPGD P15428 4/20 0.40
F2 P00734 1/20 0.40
CYP2C9 P11712 4/20 0.40
ALDH1A1 P00352 5/20 0.40
MAPT P10636 4/20 0.40
CYP3A4 P08684 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
CYP2D6 P10635 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034871 0.96 CYP11B1 (0.48) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL17034948 0.92 CYP11B1 (0.48) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL18200999 0.92 CYP19A1 (0.58) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL17034881 0.91 CYP11B1 (0.49) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL18200377 0.91 CYP19A1 (0.54) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL18200816 0.90 CYP1A2 (0.44) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL17035066 0.90 CYP11B1 (0.43) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL17035019 0.90 CYP11B1 (0.44) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL17034925 0.89 CYP1A2 (0.45) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL18201009 0.89 CYP1A2 (0.50) CYP1A2KDM4EKMT2AHPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 179/4885CYP11B1 781/4885CYP17A1 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.